All sites C00-96,D32-33,D42-43,D45-47,D76 5305 90.7 3.0 2.7 1.3 2.3
Mouth, pharynx C00-14 81 97.0 0.7 0.7 0.5 1.0
  Lip C00 8 100.0 - - - -
  Tongue C02 18 97.8 - - 1.1 1.1
  Mouth, other C03-06 26 98.5 - - 0.8 0.8
  Salivary glands C07-08 9 91.5 2.1 6.4 - -
  Pharynx C01,C09-14 19 95.7 2.2 - - 2.2
Digestive organs C15-26 887 82.3 3.9 7.1 2.8 3.9
  Oesophagus C15 32 94.3 - 1.3 2.5 1.9
  Stomach C16 76 92.4 0.8 1.8 2.4 2.6
  Small intestine C17 21 88.3 1.0 2.9 1.9 5.8
  Colon C18 318 95.7 0.2 1.7 0.7 1.8
  Rectum, rectosigmoid C19-20 140 97.0 - 1.6 0.9 0.6
  Anus C21 12 98.3 - - 1.7 -
  Liver C22 54 69.6 6.3 13.7 5.2 5.2
  Gallbladder, bile ducts C23-24 41 64.5 9.4 11.3 5.9 8.9
  Pancreas C25 178 49.7 14.4 21.5 6.7 7.6
  Other digestive organs C26 16 45.6 1.3 19.0 7.6 26.6
Respiratory organs C30-39 365 65.7 15.3 10.4 3.6 5.0
  Nose, sinuses C30-31 7 94.3 - 2.9 2.9 -
  Larynx, epiglottis C32 6 96.4 - 3.6 - -
  Lung, trachea C33-34 345 65.3 16.0 10.4 3.7 4.7
  Mediastinum, pleura C38 4 35.0 20.0 25.0 - 20.0
Bone C40-41 6 96.9 - - 3.1 -
Melanoma of the skin C43 272 99.9 - - - 0.1
Skin, non-melanoma C44 251 99.9 - - 0.1 -
Mesothelioma C45 7 100.0 - - - -
Autonomic nervous system C47 1 100.0 - - - -
Soft tissues C48-49 46 96.1 2.2 - 0.9 0.9
Breast C50 1728 99.4 0.3 0.0 0.1 0.2
Female genital organs C51-58 536 94.5 2.2 1.3 0.7 1.2
  Cervix uteri C53 54 98.5 0.7 - 0.7 -
  Corpus uteri C54 247 99.3 - 0.3 0.1 0.3
  Uterus, other C55,C58 3 50.0 7.1 7.1 7.1 28.6
  Ovary C56 150 88.4 4.9 2.8 1.5 2.4
  Other female genital C51-52,C57 82 90.3 4.9 1.9 1.2 1.7
Urinary organs C64-68 222 89.7 1.3 4.1 1.9 3.0
  Kidney C64 127 86.8 0.9 6.1 2.5 3.6
  Bladder and urinary tract2 C65-68 95 93.7 1.7 1.5 1.1 2.1
Eye C69 5 74.1 - 14.8 7.4 3.7
Brain, central nervous system C70-72,D32-33,D42-43 210 94.1 - 2.9 0.7 2.4
Thyroid gland C73 114 97.0 2.3 0.4 0.2 0.2
Other endocrine glands C74-75 7 94.6 - - - 5.4
Illdefined or unknown C76,C80 103 55.3 11.8 13.8 7.4 11.7
Lymphoid and haematopoietic tissue C81-96,D45-47,D76 463 83.0 7.3 0.8 2.1 6.9
  Hodgkin lymphoma C81 19 100.0 - - - -
  Non-Hodgkin lymphoma C82-86,C96,D76 205 97.5 0.7 0.2 0.3 1.4
  Malignant immunoproliferative diseases C88 6 90.0 3.3 3.3 3.3 -
  Myeloma and other plasma cell tumors C90 68 80.1 5.6 3.5 4.1 6.7
  Leukaemia C91-95 95 65.7 19.8 - 3.4 11.2
  Myelodysplastic syndromes D46 21 29.8 16.3 - 5.8 48.1
  Myeloproliferaitive neoplasms D45,D47 49 75.1 12.7 1.2 3.3 7.8
Not included above
  Carcinoma in situ of the breast D05 140 100.0 - - - -
  Cervix uteri, non-invasive neoplasms 301 100.0 - - - -
  Borderline tumour of the ovary D39 45 94.7 - 2.2 0.4 2.6
  Basal cell carcinoma of the skin 1574 100.0 - - - -
1 The following order of preference for confirmation of the diagnosis is used:
1. Histology (including autopsy, and bone marrow and blood smear examination in leukaemias)
2. Cytology
3. Surgery (including endoscopy), autopsy without histology, X-ray and some specified laboratory examinations
4. Clinical examination only
2 PUNLMP and ca in situ of the uroepithelium are included.